Johnson & Johnson announced today that it received FDA de novo authorization for its Ottava surgical robot system.

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with ...

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...

Since the introduction of the Da Vinci ® robotic system, robot-assisted colon resection has gained popularity because of its the potential technical advantages. Recently, two new CE-marked platforms ...

J&J received FDA authorization for OTTAVA robotic surgical system, enabling commercial launch for surgery procedures in the US. Read more.

In the interview, Zhao explains how carefully selected patients with large benign rectal polyps or early rectal cancers may be candidates for transanal minimally invasive surgery, or TAMIS — an ...

The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as it looks to compete with Intuitive Surgical and Medtronic. Ottava is now FDA-approved for multiple soft tissue surgeries, ...

Robot-assisted laparoscopic surgery was found to be more effective in harvesting lymph nodes compared with conventional surgery with similar outcomes. Surgery is the most prevalent treatment for colon ...

Nineteen patients have already undergone Robotic Assisted Surgery in the last six weeks using the new state-of-the-art system ...

Endometriosis is a chronic, estrogen-dependent inflammatory condition affecting a substantial proportion of women of ...